# MEDICUS PHARMA LTD (MDCXW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MDCXW/

- Reporting holders: 4
- Reported value: $63.6K
- Shares held by institutions: 111,203 of 63,180,610 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $39.4K | 60,600 | 0.0% | 6 |
| [Anson Funds Management LP](https://holderbook.com/funds/1491072-anson-funds-management-lp/) | $18.9K | 42,400 | 0.0% | 7 |
| [Connective Capital Management, LLC](https://holderbook.com/funds/1543568-connective-capital-management-llc/) | $3.9K | 6,000 | 0.0% | 7 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1.4K | 2,203 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 4 | $63.6K |
| Q1 2026 | 6 | $139.6K |
| Q4 2025 | 5 | $167.0K |
| Q3 2025 | 5 | $190.2K |
| Q2 2025 | 5 | $272.7K |
| Q1 2025 | 7 | $308.0K |
| Q4 2024 | 6 | $186.7K |